Back to search
FDAFDA · Food and drugs·Recall number Z-1647-2014

Dimension Vista® CSA and CSAE The Cyclosporine method is an in vitro diagnostic test for the quantitative measurement of cyclosporine A (CSA) in human whole blood on the Dimension Vista® System. Measurements of CSA are used as an aid in the management of heart, liver and kidney transplant patients.

Published May 28, 2014 · Recall initiated: March 19, 2014

Summary

FDA records medical device Class II recall Z-1647-2014, published May 28, 2014 and initiated March 19, 2014. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Terminated; Reported quantity: 4175; Lot: CSA 13114BA, exp. 2014-04-24; CSA 13157BA, exp. 2014-06-06; CSA 13246BB, exp. 2014-09-03; CSA 13317BA, exp. 2014-11-13; CSA 14008BB, exp. 2015-01-08; CSA 14050BB, exp. 2015-02-19; CSAE 13157BC, exp. 2014-06-06; CSAE 13249BD, exp. 2014-09-06. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A complaint was received of Dimension Vista® CSA and CSAE under-recovery of cyclosporine when patient samples are run from the Small Sample Container. The under-recovery that has been observed is 18 to 44%. In March 2014, Siemens recalled due to the complaint received of Dimension Vista® CSA and CSAE reporting under-recovery of cyclosporine when patient samples are run from the Small Sample C

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc.
Distributor
Worldwide Distribution - USA (nationwide) and Internationally to Canada, Belgium, Switzerland, Germany, Spain, France, Great Britain, Italy, Saudi Arabia, Australia, and Japan.
Lot
CSA 13114BA, exp. 2014-04-24; CSA 13157BA, exp. 2014-06-06; CSA 13246BB, exp. 2014-09-03; CSA 13317BA, exp. 2014-11-13; CSA 14008BB, exp. 2015-01-08; CSA 14050BB, exp. 2015-02-19; CSAE 13157BC, exp. 2014-06-06; CSAE 13249BD, exp. 2014-09-06.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Dimension Vista® CSA and CSAE The Cyclosporine method is an in vitro diagnostic test for the quantitative measurement of cyclosporine A (CSA) in human whole blood on the Dimension Vista® System. Measurements of CSA are used as an aid in the management of heart, liver and kidney transplant patients. recalled?

Yes. FDA published recall Z-1647-2014 on May 28, 2014. Reported hazard: A complaint was received of Dimension Vista® CSA and CSAE under-recovery of cyclosporine when patient samples are run from the Small Sample Container. The under-recovery that has been observed is 18 to 44%. In March 2014, Siemens recalled due to the complaint received of Dimension Vista® CSA and CSAE reporting under-recovery of cyclosporine when patient samples are run from the Small Sample C

What should I do if I have this product?

Voluntary: Firm initiated · Letter